Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Infiltration Analgesia in Total Hip Replacement
NCT02630160Phase 4Completed
- Sponsor
- Parc de Salut Mar
- Start
- Mar 2013
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in postoperative pain, sponsored by Parc de Salut Mar. Started Mar 2013; status: completed.
02
Drugs
bupivacaine hydrochloride 0.75% injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02630160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02630160.